XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $76K invested in XTL Biopharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$27K |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$2K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $45K | 25,961 | – | – |
|
|
2
Morgan Stanley
New York
| $27K | 15,861 | +5,100 | +47% |
|
|
3
UBS Group
Zurich,
Switzerland
| $2K | 1,129 | +426 | +61% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $2K | 1,000 | +1,000 | New |
|